bluebird bio appoints Michael Cloonan to Board as Class I director effective June 20, 2024

bluebird bio, Inc.

Michael Cloonan appointed as Class I director, effective June 20, 2024.
Annual retainer of $45,000; initial grant of 74,775 stock options and 37,350 RSUs.
Stock options and RSUs vest ratably over three years; standard indemnification agreement.
No family relationships with other directors/officers, no reportable transactions.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Michael Cloonan

Class I director

bluebird bio, Inc.

Effective: 2024-06-20
Filed: June 24, 2024, 7:59 PM ET

On June 20, 2024, the board of directors (the “Board”) of bluebird bio, Inc. (the “Company”) appointed Michael Cloonan to the Board as a Class I director, effective June 20, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Cloonan was appointed as Class I director at bluebird bio, Inc..

Action: appointed
Role: Class I director

Exact text from the filing

On June 20, 2024, the board of directors (the “Board”) of bluebird bio, Inc. (the “Company”) appointed Michael Cloonan to the Board as a Class I director, effective June 20, 2024.

View on SEC.gov

Source: SEC EDGAR

accession 0001193125-24-166322

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.